A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.
FASEB J
; 35(4): e21360, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33749932
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Main subject:
Antiviral Agents
/
Berberine
/
Gene Expression Regulation
/
Severe Acute Respiratory Syndrome
/
Severe acute respiratory syndrome-related coronavirus
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
/
Models, Biological
Type of study:
Guideline
Language:
En
Journal:
FASEB J
Year:
2021
Type:
Article
Affiliation country:
China